ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity.
Open access0 citations
Abstract
using RNA editing to reduce cardiometabolic risk.
// Source
Authors: Francesco De Chiara, Eva Coll-de la Rubia, Petra de Bruijn, Galja Pletikapic, Nicole Cnubben, Lianne Stevens, Emy Theunissen, Janne J. Turunen, Anita M. van den Hoek, Hans M G Princen, Wouter Beumer, Seda Yilmaz-Elis, Bart Klein, Sjef J. de Kimpe, Gerard Platenburg
Institutions: Netherlands Organisation for Applied Scientific Research, ProQR Therapeutics (Netherlands)